What's breaking now, across thousands of outlets.
(RTTNews) - On Wednesday, Pharming Group N.V. (PHAR) announced positive topline results from a Phase II study evaluating Leniolisib in patients with genetically identifiable primary immunodeficiencies (PIDs) associated with immune dysregulation linked to altered PI3Kdelta signa
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Detectives have arrested two persons of interest in connection with the fatal stabbing of Paul Mwangangi, a shoe trader at Kariokor Market, in a breakthrough in investigations into his killing.
It is not the kind of question that comes up over dinner. Yet what happens to children if parents die […]
In recent years, a series of high-profile investigations implicated the Chinese fleets targeting squid in international waters in illegal fishing practices, environmental violations, and poor working…
MUFG’s Michael Wan explains that recent RBI FX measures have supported spot Indian Rupee, while temporarily disrupting derivatives liquidity.
KUALA LUMPUR: Foreign-linked companies operating in Malaysia contributed 17.1 per cent to the national economy in 2024, according to the Statistics Department.
